Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation ; volume:13 ; number:6 ; day:28 ; month:11 ; year:2011 ; pages:1-19 ; date:12.2011
Breast cancer research ; 13, Heft 6 (28.11.2011), 1-19, 12.2011
- Creator
-
Wang, Yen-chao
- Contributor
-
Morrison, Gladys
Gillihan, Ryan
Guo, Jun
Ward, Robin M.
Fu, Xiaoyong
Botero, Maria F.
Healy, Nuala A.
Hilsenbeck, Susan G.
Phillips, Gail Lewis
Chamness, Gary C.
Rimawi, Mothaffar F.
Osborne, C Kent
Schiff, Rachel
SpringerLink (Online service)
- DOI
-
10.1186/bcr3067
- URN
-
urn:nbn:de:1111-2016032413076
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Yen-chao
- Morrison, Gladys
- Gillihan, Ryan
- Guo, Jun
- Ward, Robin M.
- Fu, Xiaoyong
- Botero, Maria F.
- Healy, Nuala A.
- Hilsenbeck, Susan G.
- Phillips, Gail Lewis
- Chamness, Gary C.
- Rimawi, Mothaffar F.
- Osborne, C Kent
- Schiff, Rachel
- SpringerLink (Online service)
Other Objects (12)
A dimension expanded preconditioning technique for block two-by-two linear equations
Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor
A comparison of two nonconforming finite element methods for linear three-field poroelasticity
Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China
Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
Metal–Organic Framework-Based Solid Acid Materials for Biomass Upgrade
A dimension expanded preconditioning technique for block two-by-two linear equations
Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor
A comparison of two nonconforming finite element methods for linear three-field poroelasticity
Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China
Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
Metal–Organic Framework-Based Solid Acid Materials for Biomass Upgrade
A dimension expanded preconditioning technique for block two-by-two linear equations
Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor
A comparison of two nonconforming finite element methods for linear three-field poroelasticity
Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China
Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2